Ocumension Therapeutics established in May 2018, is a company which focuses on the development of ophthalmic medications. The management team of the company possesses extensive experience in R&D, clinical trials, marketing and promotion, and commercial operation. With our ocular disease focus, the company strives to continuously provide important needed therapies to Chinese patients using innovative products derived from both inhouse R&D and strategic alliance with global partners.
Company Details
- Employees
- 24
- Founded
- 2018
- Address
- 上海市, Cn
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.ocumension.com
- Keywords
- Origlio.
- HQ
- 上海市
Ocumension Questions
Ocumension's website is http://www.ocumension.com
Ocumension's LinkedIn profile is https://cn.linkedin.com/company/ocumension
Ocumension has
24 employees.
View email and phone details for 24
employees at Ocumension.
Ocumension's industry is
Pharmaceutical Manufacturing
Ocumension's top competitors are
Glaukos Corporation,
Raymoonbio,
Sciclone Pharmaceuticals,
Brii Biosciences,
Nicox,
Arctic Vision Ltd.,
Bibo Biopharma Engineering Co.,ltd.,
Kyma Team,
Santen,
Alcon.
Ocumension's categories are Pharmaceutical Manufacturing
Ocumension's founding year is 2018
